Search results - ORA - Oxford University Research Archive

1 - 9 of 9

1

Journal article

COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study

Agrawal, U, Katikireddi, SV, McCowan, C, et al.
2021-09-29

2

Journal article

First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: a pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales

Kerr, S, Joy, M, Torabi, F, et al.
2022-02-22

3

Journal article

First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

Simpson, CR, Shi, T, Vasileiou, E, et al.
2021-06-09

4

Journal article

Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study

Vasileiou, E, Simpson, CR, Shi, T, et al.
2021-04-23

5

Journal article

Investigating the uptake, effectiveness and safety of COVID-19 vaccines: protocol for an observational study using linked UK national data

Vasileiou, E, Shi, T, Kerr, S, et al.
2022-02-14

6

Journal article

Variations in COVID-19 vaccination uptake among people in receipt of psychotropic drugs: cross-sectional analysis of a national population-based prospective cohort

Murphy, S, O'Reilly, D, Owen, RK, et al.
2022-03-07

7

Journal article

Effectiveness of first dose of COVID-19 vaccines against hospital admissions in Scotland: National prospective cohort study of 5.4 million people

Vasileiou, E, Simpson, CR, Robertson, C, et al.
2021

8

Journal article

Investigating the association between COVID-19 vaccination and care home outbreak frequency and duration

Bradley, DT, Murphy, S, McWilliams, P, et al.
2021-12-18

9

Journal article

Methodological issues for using a common data model (CDM) of COVID-19 vaccine uptake and important adverse events of interest (AEIs): the Data and Connectivity COVID-19 Vaccines Pharmacovigilance (DaC-VaP) United Kingdom feasibility study

Delanerolle, G, Williams, R, Stipancic, A, et al.
2022

TO TOP